FCCC LOGO Faculty Publications
Meropol NJ , Egleston BL , Buzaglo JS , Benson AB 3rd , Cegala DJ , Diefenbach MA , Fleisher L , Miller SM , Sulmasy DP , Weinfurt KP , Connect Study Research Group
Cancer patient preferences for quality and length of life
Cancer. 2008 Dec 15;113(12) :3459-66
PMID: 18988231    PMCID: PMC2606934   
Back to previous list
BACKGROUND: Optimal patient decision making requires integration of patient values, goals, and preferences with information received from the physician. In the case of a life-threatening illness such as cancer, the weights placed on quality of life (QOL) and length of life (LOL) represent critical values. The objective of the current study was to describe cancer patient values regarding QOL and LOL and explore associations with communication preferences. METHODS: Patients with advanced cancer completed a computer-based survey before the initial consultation with a medical oncologist. Assessments included sociodemographics, physical and mental health state, values regarding quality and length of life, communication preferences, and cancer-related distress. RESULTS: Among 459 patients with advanced cancer, 55% placed equal valued on QOL and LOL, 27% preferred QOL, and 18% preferred LOL. Patients with a QOL preference had lower levels of cancer-related distress (P < .001). A QOL preference was also associated with older age (P = .001), male sex (P = .003), and higher educational level (P = .062). Patients who preferred LOL over QOL desired a more supportive and less pessimistic communication style from their oncologists. CONCLUSIONS: These data indicate that a values preference for LOL versus QOL may be simply measured, and is associated with wishes regarding the nature of oncologist communication. Awareness of these values during the clinical encounter could improve decision making by influencing the style and content of the communication between oncologists and their patients.
Meropol, Neal J Egleston, Brian L Buzaglo, Joanne S Benson, Al B 3rd Cegala, Donald J Diefenbach, Michael A Fleisher, Linda Miller, Suzanne M Sulmasy, Daniel P Weinfurt, Kevin P P30CA06927/CA/NCI NIH HHS/United States R01CA082085/CA/NCI NIH HHS/United States Randomized Controlled Trial Research Support, N.I.H., Extramural United States Cancer Cancer. 2008 Dec 15;113(12):3459-66.